Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fusion Pharmaceuticals Inc. | Chief Technology Officer | Common Stock | 0 | $0 | $2.03 | Jun 4, 2024 | Direct |
Fusion Pharmaceuticals Inc. | Chief Technology Officer | Restricted Stock Units | 0 | $0 | $2.03 | Jun 4, 2024 | Direct |
Fusion Pharmaceuticals Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 0 | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FUSN | Fusion Pharmaceuticals Inc. | Jun 4, 2024 | 15 | $0 | 4 | Jun 4, 2024 | Chief Technology Officer |
FUSN | Fusion Pharmaceuticals Inc. | Jan 4, 2024 | 2 | $0 | 4 | Jan 5, 2024 | Chief Technology Officer |
FUSN | Fusion Pharmaceuticals Inc. | Jan 5, 2023 | 1 | $0 | 4 | Jan 9, 2023 | Chief Technology Officer |
FUSN | Fusion Pharmaceuticals Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief? Scientific Officer |